Biotech Values

[JJM760]

If someone at ARIA actually said this, it’s a rather extreme case of hyperbole. I continue to find these kinds of remarks, of which there have recently been several, to be mildly bearish.

From the second page:

Ariad Pharmaceuticals, a Cambridge company, is developing drugs that will block all the mutations through which a particular cancer could overcome a treatment.

Even with a strategy aimed at cutting off all escape routes, however, the company’s founder and chief executive, Dr. Harvey Berger, said it was important not to underestimate the opposition.

“Never bet against biology; never bet against a cancer cell. They’re too ‘smart,’ so I’ll never say that it’s impossible that a mutation can grow out,’’ Berger said.